CAI Caris Life Sciences, Inc.

NASDAQ
$26.05

Caris Life Sciences, Inc. (CAI) SEC Filings

Everything CAI has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

40 filings
Date Form Filing
8-K Investor Presentation · Reg Fd
4
144
144
144
4
4
4
4
4
4
4
4
144
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.